Casellas F, Rodrigo L, Vivancos J López, Riestra S, Pantiga C, Baudet J S, Junquera F, Diví V Puig, Abadia C, Papo M, Gelabert J, Malagelada J R
Digestive System Research Unit, Hospital Universitari Vall d'Hebron, Pg Vall d'Hebron 119-129, Barcelona 08035, Spain.
World J Gastroenterol. 2008 Jan 7;14(1):46-52. doi: 10.3748/wjg.14.46.
To evaluate the factors involved in the impairment of health-related quality of life (HRQOL) in patients with celiac disease.
A multicenter, cross-sectional prospective study was performed in patients with celiac disease who completed two HRQOL questionnaires: the gastrointestinal quality of life index (GIQLI) and the EuroQol-5D (EQ).
Three hundred and forty patients (163 controlled with a gluten-free diet, and 177 newly diagnosed with a normal diet) were included. The GIQLI score was significantly better in patients on a gluten-free diet (GFD) than in non-treated patients on their usual diet, both in terms of the overall score (3.3 vs 2.7, respectively; P < 0.001), as well as on the individual questionnaire dimensions. Both the preference value of the EQ as the visual analogue scale were significantly better in treated than in non-treated patients (0.93 vs 0.72 P < 0.001 and 80 vs 70 P < 0.001, respectively). Variables significantly associated with a worse HRQOL score were female gender, failure to adhere to a GFD, and symptomatic status.
In untreated celiac disease, the most important factors that influence patient perception of health are the presence of symptoms and a normal diet. HRQOL improves to levels similar to those described in the general population in celiac disease patients well controlled with a GFD.
评估乳糜泻患者健康相关生活质量(HRQOL)受损的相关因素。
对乳糜泻患者进行了一项多中心横断面前瞻性研究,这些患者完成了两份HRQOL问卷:胃肠道生活质量指数(GIQLI)和欧洲五维健康量表(EQ)。
纳入了340例患者(163例采用无麸质饮食控制,177例新诊断且采用正常饮食)。无论是总体评分(分别为3.3和2.7;P < 0.001)还是在单个问卷维度方面,采用无麸质饮食(GFD)的患者的GIQLI评分均显著优于采用常规饮食的未治疗患者。EQ的偏好值和视觉模拟量表在治疗患者中均显著优于未治疗患者(分别为0.93对0.72,P < 0.001和80对70,P < 0.001)。与较差的HRQOL评分显著相关的变量为女性、未坚持GFD饮食以及有症状状态。
在未经治疗的乳糜泻中,影响患者健康认知的最重要因素是症状的存在和正常饮食。在采用GFD良好控制的乳糜泻患者中,HRQOL改善至与一般人群中描述的水平相似。